MoneyWorks4Me

Cadila Healthcare informs about press release

23 Apr 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated April 23, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Propafenone Hydrochloride Extended-Release Capsules’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..